Sanofi Website

Sanofi

ENXTPA-SAN

Basic

  • Market Cap

    €112.37B

  • EV

    €122.4B

  • Shares Out

    1,250.12M

  • Revenue

    €46.29B

  • Employees

    86,088

Margins

  • Gross

    68.51%

  • EBITDA

    26.36%

  • Operating

    19.03%

  • Pre-Tax

    12.7%

  • Net

    9.8%

  • FCF

    18.55%

Returns (5Yr Avg)

  • ROA

    6.03%

  • ROTA

    14.04%

  • ROE

    10.9%

  • ROCE

    8.75%

  • ROIC

    7.04%

Valuation (TTM)

  • P/E

  • P/B

  • EV/Sales

  • EV/EBITDA

  • P/FCF

  • EV/Gross Profit

Valuation (NTM)

  • Price Target

    €108.19

  • P/E

  • PEG

  • EV/Sales

  • EV/EBITDA

  • P/FCF

Financial Health

  • Cash

    €8,710M

  • Net Debt

    €9,713M

  • Debt/Equity

    0.25

  • EBIT/Interest

    14.39

Growth (CAGR)

  • Rev 3Yr

    7.81%

  • Rev 5Yr

    5%

  • Rev 10Yr

    3.42%

  • Dil EPS 3Yr

    -27.99%

  • Dil EPS 5Yr

    0.49%

  • Dil EPS 10Yr

    2.4%

  • Rev Fwd 2Yr

    7.63%

  • EBITDA Fwd 2Yr

    4.2%

  • EPS Fwd 2Yr

    3.91%

  • EPS LT Growth Est

    7.14%

Dividends

  • Yield

  • Payout

    87.16%

  • DPS

    €3.76

  • DPS Growth 3Yr

    5.52%

  • DPS Growth 5Yr

    4.14%

  • DPS Growth 10Yr

    2.99%

  • DPS Growth Fwd 2Yr

    4.05%

Select a metric from the list below to chart it

Dec '14

Dec '15

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

LTM

Dec '24 (E)

Dec '25 (E)

Dec '26 (E)

Operating Revenues

36,126

36,041

37,761

42,997

43,070

43,312

Other Revenues, Total

1,505

1,328

1,414

2,392

2,963

2,976

Total Revenues

37,631

37,369

39,175

45,389

46,033

46,288

Total Revenues % Chg.

5.5%

-0.7%

4.8%

15.9%

1.4%

0.2%

Cost of Goods Sold, Total

11,976

12,106

12,251

13,692

14,216

14,576

Gross Profit

25,655

25,263

26,924

31,697

31,817

31,712

Selling General & Admin Expenses, Total

9,967

9,448

9,599

10,539

10,765

10,763

R&D Expenses

6,020

5,530

5,692

6,706

6,728

6,884

Amortization of Goodwill and Intangible Assets

2,146

1,681

1,580

1,827

2,172

2,245

Other Operating Expenses

720

1,025

1,488

1,587

2,950

3,012

Other Operating Expenses, Total

18,853

17,684

18,359

20,659

22,615

22,904

Operating Income

6,802

7,579

8,565

11,038

9,202

8,808

Interest Expense, Total

-544

-459

-362

-394

-527

-612

Interest And Investment Income

91

37

3

173

546

536

Net Interest Expenses

-453

-422

-359

-221

19

-76

Income (Loss) On Equity Invest.

255

359

39

68

-115

-164

Currency Exchange Gains (Loss)

1

-6

2

-4

-2

-2

Other Non Operating Income (Expenses)

236

144

70

37

-665

-665

EBT, Excl. Unusual Items

6,841

7,654

8,317

10,918

8,439

7,901

Restructuring Charges

-1,088

-1,089

-820

-1,336

-1,490

-1,990

Merger & Related Restructuring Charges

-3

-53

-4

-3

-20

-20

Gain (Loss) On Sale Of Investments

7,388

3

1

-1

-1

Gain (Loss) On Sale Of Assets

296

443

418

655

688

580

Asset Writedown

-3,604

-330

-192

228

-896

-864

Legal Settlements

327

-79

Other Unusual Items

238

124

115

27

318

353

EBT, Incl. Unusual Items

3,007

14,137

7,837

10,490

7,038

5,880

Income Tax Expense

121

1,807

1,558

2,006

1,602

1,307

Earnings From Continuing Operations

2,886

12,330

6,279

8,484

5,436

4,573

Earnings Of Discontinued Operations

-101

Minority Interest

-31

-36

-56

-113

-36

-35

Net Income

2,754

12,294

6,223

8,371

5,400

4,538

Net Income to Common Incl Extra Items

2,754

12,294

6,223

8,371

5,400

4,538

Net Income to Common Excl. Extra Items

2,855

12,294

6,223

8,371

5,400

4,538

Total Shares Outstanding

1,253.8

1,250.7

1,252.5

1,252.6

1,251.3

1,248.8

Weighted Avg. Shares Outstanding

1,249.9

1,253.6

1,252.5

1,251.9

1,251.7

1,251.6

Weighted Avg. Shares Outstanding Dil

1,257.1

1,260.1

1,257.9

1,256.9

1,256.4

1,256.3

EPS

2.2

9.8

5

6.7

4.3

3.6

EPS Diluted

2.2

9.8

5

6.7

4.3

3.6

EBITDA

10,113

10,466

11,251

14,062

12,520

12,199.5

Effective Tax Rate

4%

12.8%

19.9%

19.1%

22.8%

22.2%